Literature DB >> 30267739

Inhibition of NRF2 signaling and increased reactive oxygen species during embryogenesis in a rat model of retinoic acid-induced neural tube defects.

Dan Liu1, Jia Xue1, Yusi Liu1, Hui Gu1, Xiaowei Wei1, Wei Ma1, Wenting Luo1, Ling Ma1, Shanshan Jia1, Naixuan Dong1, Jieting Huang1, Yanfu Wang1, Zhengwei Yuan2.   

Abstract

Exposure to retinoic acid (RA) during pregnancy increases the risk of serious neural tube defects (NTDs) in the developing fetus. The precise molecular mechanism for this process is unclear; however, RA is associated with oxidative stress mediated by reactive oxygen species. Nuclear factor erythroid 2-related factor 2 (NRF2) is a master regulator of oxidative stress that directs the expression of antioxidant genes and detoxifying proteins to maintain redox homeostasis. We established a rat model of NTDs in which pregnant dams were administered all-trans (at)RA on gestational day 10, and oxidative stress levels and the spatiotemporal expression of NRF2 and its downstream targets were examined in the resulting embryos and in maternal blood. In the NTD group, total antioxidative capacity decreased and 8-hydroxy-2'-deoxyguanosine increased in maternal serum and fetal spinal cord tissues. Plasma GSH content, the GSH/GSSG ratio, and glutathione peroxidase activity in fetal spinal cords were lower in the NTD group relative to controls. We detected NRF2 protein reduction and concomitant upregulation of Kelch-like ECH-associated protein 1 (KEAP1) - a cytoplasmic inhibitor of NRF2 - in the NTD group. The mRNA and protein levels of downstream targets of NRF2 were downregulated in the spinal cords of NTD embryos. These data demonstrate substantial oxidative stress and NRF2 signaling pathway disruption in a model of NTDs induced by atRA. The inhibitory effects of atRA on NRF2 signaling may lower cellular defenses against RA-induced oxidative stress and could play important roles in NTD occurrence during embryonic development.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NRF2; Neural tube defects; Oxidative stress; Retinoic acid

Mesh:

Substances:

Year:  2018        PMID: 30267739     DOI: 10.1016/j.neuro.2018.09.005

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  6 in total

Review 1.  The Redox Theory of Development.

Authors:  Jason M Hansen; Dean P Jones; Craig Harris
Journal:  Antioxid Redox Signal       Date:  2020-04-01       Impact factor: 8.401

2.  Unraveling the Mechanisms of Clinical Drugs-Induced Neural Tube Defects Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Zhen Guan; Yingchao Liang; Xiuwei Wang; Zhiqiang Zhu; Aiyun Yang; Shen Li; Jialu Yu; Bo Niu; Jianhua Wang
Journal:  Neurochem Res       Date:  2022-08-12       Impact factor: 4.414

3.  Whole-Exome Sequencing Identifies Damaging de novo Variants in Anencephalic Cases.

Authors:  Linlin Wang; Aiguo Ren; Tian Tian; Nan Li; Xuanye Cao; Peng Zhang; Lei Jin; Zhiwen Li; Yan Shen; Bo Zhang; Richard H Finnell; Yunping Lei
Journal:  Front Neurosci       Date:  2019-11-29       Impact factor: 4.677

4.  Homocysteine-induced neural tube defects in chick embryos via oxidative stress and DNA methylation associated transcriptional down-regulation of miR-124.

Authors:  Rui Wang; Zhong-Ji Han; Ge Song; Yi Cui; Hong-Fei Xia; Xu Ma
Journal:  Toxicol Res (Camb)       Date:  2021-04-26       Impact factor: 3.524

5.  Post-Treatment of Synthetic Polyphenolic 1,3,4 Oxadiazole Compound A3, Attenuated Ischemic Stroke-Induced Neuroinflammation and Neurodegeneration.

Authors:  Arooj Mohsin Alvi; Lina Tariq Al Kury; Muhammad Umar Ijaz; Fawad Ali Shah; Muhammad Tariq Khan; Ahmed Sadiq Sheikh; Humaira Nadeem; Arif-Ullah Khan; Alam Zeb; Shupeng Li
Journal:  Biomolecules       Date:  2020-05-26

Review 6.  The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology.

Authors:  Juha M T Hyttinen; Ram Kannan; Szabolcs Felszeghy; Minna Niittykoski; Antero Salminen; Kai Kaarniranta
Journal:  Int J Mol Sci       Date:  2019-11-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.